NCT06654557 Effect of Adding Glycerol to Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest
| NCT ID | NCT06654557 |
| Status | Recruiting |
| Phase | — |
| Sponsor | PepsiCo Global R&D |
| Condition | Fluid Balance |
| Study Type | INTERVENTIONAL |
| Enrollment | 95 participants |
| Start Date | 2024-09-30 |
| Primary Completion | 2025-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 95 participants in total. It began in 2024-09-30 with a primary completion date of 2025-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The results of a prior study PEP-2311 suggested there was a positive dose-response effect of glycerol and sodium on fluid balance and fluid retention. In addition, inclusion of glycerol resulted in an upward shift in the relationship between sodium concentration and fluid balance. The practical interpretation is that addition of glycerol enables a reduction in sodium concentration compared with a 0% glycerol drink. In this follow-up study, the investigators hypothesize that 1) fluid balance will be sustained (greater than or not different from baseline) and significantly greater than placebo for 120 min after drinking the test no/low/moderate carbohydrate beverages and 2) fluid balance will not differ between the carbohydrate-electrolyte beverages, but both will be greater than placebo.
Eligibility Criteria
Inclusion Criteria: Subject is male or female * If female, subject is not pregnant (based on self-report) * Subject is 18-50 years of age, inclusive Subject is at least recreationally active (engaged in light to moderate intensity, intermittent, or steady-state exercise at least 3 days per week for at least 30 min at a time) * Subject does not smoke (or has quit for at least 6 months) * Subject is not taking medication that may interfere with the study (e.g., diuretics) * Subject has no health conditions that would interfere with the study, As indicated on the general health questionnaire (GHQ), e.g. cardiovascular, renal, or metabolic diseases * Subject is not allergic to adhesives (e.g., medical tape) * Subject is not allergic to kiwi-strawberry flavoring * Subject is willing to avoid alcohol consumption 24 hours prior to visit(s) * Subject is willing to fast overnight (\~8-12 hours) * Subject is willing to refrain from vigorous exercise for 24 hours (light physical activity only) * Subject is willing to eat the exact same food the day prior to each visit to the laboratory * Able to speak, write, and read English * Provision of written consent to participate Exclusion Criteria: * Subject has participated in a clinical trial within the past 30 days * Subject has participated in any PepsiCo trial within past 6 months * Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk * Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.
Contact & Investigator
Lindsay Baker, PhD
PRINCIPAL INVESTIGATOR
PepsiCo R&D Life Sciences, Sports Science
Frequently Asked Questions
Who can join the NCT06654557 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Fluid Balance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06654557 currently recruiting?
Yes, NCT06654557 is actively recruiting participants. Contact the research team at Lindsay.Baker@pepsico.com for enrollment information.
Where is the NCT06654557 trial being conducted?
This trial is being conducted at Valhalla, United States.
Who is sponsoring the NCT06654557 clinical trial?
NCT06654557 is sponsored by PepsiCo Global R&D. The principal investigator is Lindsay Baker, PhD at PepsiCo R&D Life Sciences, Sports Science. The trial plans to enroll 95 participants.